Aparito Win Daily Post Business Award for Innovation and Technology

Aparito, a Wrexham-based MedTech company, won the Innovation and Technology Award at the 2021 Daily Post Business Awards for their Atom5TM clinical trial software platform.

The award recognises the transformational work of Aparito’s software developers, data scientists and support teams who help bring clinical trials to patients and unlock real-world data through the Atom5TM platform, video assessments & wearable devices, making it simpler for more diverse patient groups to engage in clinical trials by reducing the time and cost required to participate.

“We’re thrilled to win this award and have the work of a Wrexham company that competes with global businesses recognised by the judges. North Wales is a vibrant and supportive location for tech companies and has helped us build a world-class team who in turn have built a world-class platform.

Diolch yn fawr iawn i’r Daily Post a Prifysgol Bangor.”

Dr Elin Haf Davies, Founder & CEO of Aparito

Notes to Editors

About Aparito

Aparito is a global health tech company headquartered in Wrexham that brings clinical trials to patients and unlocks real-world data through mobile apps, video assessments & wearable devices.

We provide innovative patient-centric solutions that integrate required clinical & regulatory expertise to capture patient data and develop digital endpoints for hybrid and decentralised clinical trials.

We do all this through Atom5, our iOS & Android-compatible web and mobile app platform.

Atom5 captures multiple, high-frequency data points from video, voice, wearables and ePRO and, analyses the data in conjunction with our team of data scientists to provide rich, real-time insights to clinical teams.

The Atom5 global platform operates under ISO143485 QMS and ISO/IEC 27001 ISMS accreditations and is FDA CFR21 Part 11 compliant.

Image via https://twitter.com/business_owen


Attached Media


Press Contacts